White L L, Holimon T D, Tepedino J T, Portner T S, Wan J Y, Thompson J W
Integrated Pharmacy Solutions, Inc., Memphis, TN, USA.
Am J Health Syst Pharm. 1996 Dec 15;53(24):2963-9. doi: 10.1093/ajhp/53.24.2963.
Antimicrobial prescribing patterns for Tennessee Medicaid children having their first case of otitis media (OM) in at least nine months were studied. Tennessee Medicaid claims data for patients under 11 years whose first documented OM diagnosis in 1993 occurred in the fourth quarter and who had had an antimicrobial claim filed within two days of diagnosis were studied to determine antimicrobial prescribing patterns. Of 7357 children meeting the study criteria, 70% were less than three years of age, 65% were Caucasian, and 60% had a rural address. Twenty antimicrobials were prescribed. Amoxicillin was prescribed most frequently (53% of the time), followed by cefaclor; all first-line therapies (amoxicillin, ampicillin, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole) accounted for 64% of the prescriptions, but only one fourth of the costs. The highest use of first-line therapy was associated with children under three years of age; children without prior antimicrobial therapy, recent upper respiratory infection (URI), or recent sinusitis; children seen by emergency department physicians; and children seen by urban physicians. Tennessee Medicaid would have saved +68,250 if first-line therapy had been used for all children having their first occurrence of OM in the fourth quarter alone. The savings to the state were estimated at +300,000 or more in 1993 had first-line therapy been used for most first occurrences of OM in all four quarters plus even a small percentage of the estimated 30,000 remaining repeat OM cases. Amoxicillin was prescribed 53% of the time, and all first-line therapies 64% of the time, for children with their first case of OM in at least nine months. In children without recent antimicrobial therapy, URI, or sinusitis, first-line therapy was still used only 72% of the time.
对田纳西州医疗补助计划中至少九个月内首次患中耳炎(OM)的儿童的抗菌药物处方模式进行了研究。研究了1993年第四季度首次记录OM诊断且在诊断后两天内提交抗菌药物索赔的11岁以下患者的田纳西州医疗补助计划索赔数据,以确定抗菌药物处方模式。在符合研究标准的7357名儿童中,70%年龄小于三岁,65%为白种人,60%居住在农村。共开出了20种抗菌药物。阿莫西林的处方最为频繁(占53%),其次是头孢克洛;所有一线治疗药物(阿莫西林、氨苄西林、红霉素 - 磺胺异恶唑和甲氧苄啶 - 磺胺甲恶唑)占处方的64%,但仅占费用的四分之一。一线治疗的最高使用率与三岁以下儿童、无先前抗菌药物治疗史、近期无急性上呼吸道感染(URI)或近期无鼻窦炎的儿童、急诊科医生诊治的儿童以及城市医生诊治的儿童相关。如果仅对第四季度首次患OM的所有儿童使用一线治疗,田纳西州医疗补助计划本可节省68,250美元。如果在所有四个季度中对大多数首次患OM的病例以及估计的30,000例剩余复发性OM病例中的一小部分使用一线治疗,1993年该州的节省估计可达300,000美元或更多。对于至少九个月内首次患OM的儿童,阿莫西林的处方时间占53%,所有一线治疗药物的处方时间占64%。在无近期抗菌药物治疗、URI或鼻窦炎的儿童中,一线治疗的使用率仍仅为72%。